Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > T. Matthew Wiley > Profile

T. Matthew Wiley

Affiliations

  • Other at Bioxcel Therapeutics Inc. (BTAI), 2025-04-01
  • Chief Commercial Officer at Mind Medicine (Mindmed) Inc. (MNMD), 2025-03-18
  • Chief Commercial Officer at Vyne Therapeutics Inc. (VYNE), 2021-04-02
  • Chief Commercial Officer at Foamix Pharmaceuticals Ltd. (FOMX), 2020-03-11
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FOMX $3.76 13,440 $50,534.40 63,440 2019-03-05 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BTAI $0.55 6,272 $3,449.60 19,011 2024-10-03 Filing
BTAI $0.69 215 $148.52 4,033 2024-09-16 Filing
BTAI $1.26 244 $308.10 3,498 2024-06-17 Filing
BTAI $2.64 1,008 $2,656.18 2,992 2024-04-04 Filing